Article Details

VLP BioTech, Inc. Announces an Immunotherapy Designed for the Treatment of Chronic HBV/HDV ...

Retrieved on: 2021-02-24 13:52:30

Tags for this article:

Click the tags to see associated articles and topics

VLP BioTech, Inc. Announces an Immunotherapy Designed for the Treatment of Chronic HBV/HDV .... View article details on hiswai:

Excerpt

... for the efficacy of a peptide-based viral entry inhibitor (Hepcludex). VLP BioTech is announcing the development of a more practical vaccine-based, ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo